Experiment 561444

Worktypes

PATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SOPHORAFLAVANONE G

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
OrganismSophora exigua (FABACEAE)
CitationIINUMA,M: TSUCHA,H: SATO,M: FUJIWARA,S:. (1995). ANTICARIES AGENTS CONTAINING SOPHORA EXIGUA EXTRACTS AND BACTERICIDES CONTAINING LAVANDULYLFLAVANONES.. ()
Amount utilized
Compound isolated
Disease5,7,2,4'-TETRAHYDROOXY-8-LAVANDULYLFAVANONE (SOPHORAFLAVANONE G) (II). (II) INHIBITED STREPTOCOCCUS MUTAN, S. RATTUS, S. CRICETUS, S. ORALIS, S. SANGUIS, S. MITIA, S. GORDONII, S. PYROGENES, AND S. SALIVARIUS WITH MIN. INHIBITORY CONCNS. OF 3.13-12.5 UG/ML. VS. >50 UG/ML, FOR QUERCETIN.
Dose amountVAR MCG
Number4
Qualitative resultACTIVE
AnimalAGAR PLATE
Per unitML
Dose expressionMIC